NATCO PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 999.4 INR | +0.43% |
|
+2.56% | +23.18% |
| May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
| May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
Past dividends on NATCO Pharma Limited
| 2024-02-25 | Interim Payment 1.25 INR |
| 2023-11-23 | Interim Payment 1.25 INR |
| 2023-08-21 | Interim Payment 7 INR |
| 2023-02-20 | Interim Payment 1.25 INR |
| 2022-11-20 | Interim Payment 0.75 INR |
| 2022-08-18 | Interim Payment 3.5 INR |
| 2022-02-23 | Interim Payment 2 INR |
| 2021-11-22 | Interim Payment 0.5 INR |
| 2021-08-23 | Interim Payment 2 INR |
| 2021-02-21 | Interim Payment 1 INR |
| 2020-11-23 | Interim Payment 3 INR |
| 2020-08-20 | Interim Payment 1.25 INR |
| 2020-06-25 | Interim Payment 1 INR |
| 2020-02-23 | Interim Payment 3.5 INR |
| 2019-11-20 | Interim Payment 1 INR |
| 2019-08-21 | Interim Payment 1.25 INR |
| 2019-06-05 | Interim Payment 1.25 INR |
| 2019-02-20 | Interim Payment 3.5 INR |
| 2018-08-19 | Interim Payment 1.5 INR |
| 2018-02-14 | Interim Payment 7 INR |
| 2017-08-15 | Interim Payment 1.25 INR |
| 2017-02-22 | Interim Payment 6 INR |
| 2016-08-18 | Interim Payment 0.75 INR |
| 2016-02-21 | Interim Payment 1.25 INR |
| 2015-02-23 | Interim Payment 5 INR |
| 2014-02-23 | Interim Payment 5 INR |
| 2013-02-21 | Interim Payment 4 INR |
| 2012-02-21 | Interim Payment 3 INR |
| 2011-02-23 | Interim Payment 2 INR |
| 2010-02-04 | Interim Payment 2 INR |
| 2009-06-03 | Interim Payment 1.25 INR |
| 2007-11-11 | Interim Payment 1.25 INR |
| 2006-11-09 | Annual 1.25 INR |
| 2005-11-09 | Annual 1.25 INR |
- Stock Market
- Equities
- NATCOPHARM Stock
- Charts NATCO Pharma Limited
- Total Return chart
